- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/20 - Nitrogen atoms
Patent holdings for IPC class C07D 237/20
Total number of patents in this class: 314
10-year publication summary
|
24
|
13
|
20
|
24
|
23
|
23
|
20
|
24
|
15
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10263 |
25 |
| BASF SE | 21303 |
9 |
| Janssen Pharmaceutica N.V. | 3171 |
8 |
| Northwestern University | 3540 |
7 |
| Xenon Pharmaceuticals Inc. | 196 |
7 |
| Bayer AG | 3495 |
6 |
| Arcus Biosciences, Inc. | 164 |
6 |
| Nihon Nohyaku Co., Ltd. | 324 |
6 |
| Corteva Agriscience LLC | 2645 |
6 |
| Bristol-myers Squibb Company | 4729 |
5 |
| Bayer Pharma AG | 1014 |
5 |
| Oryzon Genomics S.A. | 103 |
5 |
| Autobahn Therapeutics, Inc. | 44 |
5 |
| Board of Regents, The University of Texas System | 6102 |
4 |
| PTC Therapeutics, Inc. | 475 |
4 |
| UniQuest Pty Limited | 35 |
4 |
| Skyhawk Therapeutics, Inc. | 148 |
4 |
| Raze Therapeutics, Inc. | 18 |
4 |
| Centre National de La Recherche Scientifique | 11016 |
3 |
| Takeda Pharmaceutical Company Limited | 2715 |
3 |
| Other owners | 188 |